Active Ingredient: LOTEPREDNOL ETABONATE
Proprietary Name: LOTEPREDNOL ETABONATE
Dosage Form; Route of Administration: GEL; OPHTHALMIC
Strength: 0.5%
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A215384
Product Number: 001
Approval Date: Aug 9, 2023
Applicant Holder Full Name: SUN PHARMACEUTICAL INDUSTRIES LTD
Marketing Status:
Prescription
Patent and Exclusivity Information